260 likes | 434 Views
Pioneering Research . Study DG-031-CV-301 is a truly pioneering clinical trialTo our knowledge it is the first example of a Phase III clinical trial in a common disease in which the drug is designed to affect a disease pathway that has been identified based on genetic/genomic research . Need for Be
E N D